Discover trends, market shifts, and competitive outlooks for the antiemetics and antinauseants industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Antiemetics And Antinauseants Market, and What Factors Will Drive It?

In recent times, the market size for antiemetics and antinauseants has steadily expanded. The market breadth is projected to increase from $8.11 billion in 2024 to $8.45 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. Factors such as historical branding, market competition, historical treatment preferences, economic circumstances, past global health occurrences, and progress in medical research and advancements have played a pivotal role in the market’s growth during the historical period.

In the forthcoming years, the market for antiemetics and antinauseants is predicted to witness stable growth. It’s expected to expand to a value of $9.7 billion in 2029, with a compound annual growth rate (CAGR) of 3.5%. The growth during this projected period can be connected to research and development efforts, economic situations, market rivalry, and trends within the industry, as well as alterations in sickness patterns, and healthcare rules and regulations. The anticipated period exhibits major trends such as an intensified focus on patient experience, evolving healthcare policies, customer inclination towards noninvasive treatments, increasing cases of nausea related to chemotherapy and pregnancy, and the introduction of targeted therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What External and Internal Drivers Are Contributing to the Growth of theAntiemetics And Antinauseants Market?

The market for antiemetics and antinauseants has been propelled by a rise in the occurrence rate of cancer. With chemotherapy being a universally accepted treatment for cancer, its resultant side effects such as nausea and vomiting (CINV) often require additional care. This is where antiemetics come in, offering prevention against CINV in around 60%-70% of those undergoing treatment. For example, in April 2024, The American Cancer Society, a US-based non-profit organization, estimated that a total of approximately 609,000 lives were lost to cancer and around 1.9 million new cases were detected in the country in 2022. Further projections suggest that about 620,000 cancer fatalities are expected in 2024, indicating a slight rise in death rates. This escalating incidence of cancer will invariably boost the need for antiemetics and antinauseants, hence propelling market revenue.

What Segment Types Define the Antiemetics And Antinauseants Market Structure?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Antiemetics And Antinauseants Market?

Top firms in the antiemetic and antinauseant markets are focusing on the development of innovative products, such as ready-to-use injectables, to simplify treatment procedures and improve patient adherence. These easy-to-use injectable products are engineered to provide instant relief, lessening time and difficulty linked with regular injectable drugs. For example, Amneal Pharmaceuticals, a specialty pharmaceutical company based in the US, in July 2024, introduced FOCINVEZ, the first-ever ready-to-use injectable version of fosaprepitant, meant to deter acute and delayed nausea and sickness associated with highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, does not contain Polysorbate 80 and is exempted from reconstitution or dilution, thus enabling direct administration. FOCINVEZ has gained approval for use in adults and pediatric patients as young as six months and has been allotted a distinctive J-Code (J1434) for reimbursement purposes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Is the Definition of the Antiemetics And Antinauseants Market?

The antiemetics and antinauseants refer to drugs that are used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. Antiemetic and antinauseant drugs prevent, control, or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu, or chemotherapy. These drugs reduced the symptoms of nausea or vomiting by blocking signal messages to the part of the brain that controls nausea and vomiting.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model